Literature DB >> 29042332

The Relevance of Simpson Grade Resections in Modern Neurosurgical Treatment of World Health Organization Grade I, II, and III Meningiomas.

Jeff S Ehresman1, Tomas Garzon-Muvdi1, Davis Rogers1, Michael Lim1, Gary L Gallia1, Jon Weingart1, Henry Brem1, Chetan Bettegowda1, Kaisorn L Chaichana2.   

Abstract

OBJECTIVE: The Simpson grading system has played an important role in surgical resections of meningiomas. The aim of this study was to determine if this grading system predicts meningioma recurrence in a modern cohort of patients with tumors of all World Health Organization grades.
METHODS: Adult patients who underwent primary, nonbiopsy resection of a meningioma at a tertiary care institution between 2007 and 2015 were retrospectively reviewed. Stepwise multivariate proportional hazard analyses were used to identify associations with recurrence after resection. Log-rank analyses were used to compare Kaplan-Meier plots for time to recurrence between each Simpson grade.
RESULTS: Of 572 patients who met inclusion criteria, 72 (12.6%) presented with recurrence. Factors associated with recurrence after gross total resection (Simpson grades I-III) were non-World Health Organization grade I (hazard ratio [HR] [95% confidence interval (CI)] 6.215 [2.864-12.419], P < 0.0001) and preoperative neurologic deficits (HR [95% CI] 2.862 [1.512-5.499], P = 0.001). Factors associated with recurrence after subtotal resections (Simpson IV) were African American race (HR [95% CI] 2.776 [1.232-5.890], P = 0.02) and parafalcine location (HR [95% CI] 3.956 [1.624-8.775], P = 0.004). Simpson grade was not an independent risk factor for recurrence.
CONCLUSIONS: Identification and consideration of factors associated with recurrence after gross total or subtotal resections may help guide treatment strategies for patients with meningiomas.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Meningioma; Recurrence; Risk factors; Simpson grade; WHO grade

Mesh:

Year:  2017        PMID: 29042332     DOI: 10.1016/j.wneu.2017.10.028

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  9 in total

1.  The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis.

Authors:  Victor M Lu; Anshit Goyal; Adrian Lee; Mark Jentoft; Alfredo Quinones-Hinojosa; Kaisorn L Chaichana
Journal:  J Neurooncol       Date:  2018-12-01       Impact factor: 4.130

2.  Value of K i -67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas.

Authors:  Jose Gabrielle Matias; Ignacio Jusue-Torres; Brendan Martin; Ankush Bajaj; Ewa Borys; Edward Melian; Kevin Barton; Douglas E Anderson; Vikram C Prabhu
Journal:  J Neurol Surg B Skull Base       Date:  2018-09-06

3.  Clinical and histopathological predictors of outcome in malignant meningioma.

Authors:  Andrea D Maier; Jiri Bartek; Frank Eriksson; Heidi Ugleholdt; Marianne Juhler; Helle Broholm; Tiit I Mathiesen
Journal:  Neurosurg Rev       Date:  2019-03-13       Impact factor: 3.042

Review 4.  The Simpson Grading: Is It Still Valid?

Authors:  Silky Chotai; Theodore H Schwartz
Journal:  Cancers (Basel)       Date:  2022-04-15       Impact factor: 6.575

5.  Postoperative radiotherapy for meningiomas - a decision-making analysis.

Authors:  Thomas Hundsberger; Paul Martin Putora; Galina Farina Fischer; Detlef Brügge; Nicolaus Andratschke; Brigitta Gertrud Baumert; Davide Giovanni Bosetti; Francesca Caparrotti; Evelyn Herrmann; Alexandros Papachristofilou; Susanne Rogers; Lucia Schwyzer; Daniel Rudolf Zwahlen
Journal:  BMC Cancer       Date:  2022-05-04       Impact factor: 4.638

6.  Extent of Resection in Meningioma: Predictive Factors and Clinical Implications.

Authors:  Jean-Michel Lemée; Marco V Corniola; Michele Da Broi; Holger Joswig; David Scheie; Karl Schaller; Eirik Helseth; Torstein R Meling
Journal:  Sci Rep       Date:  2019-04-11       Impact factor: 4.379

7.  Retrospective Analysis and Comparison of 48 Intracranial Meningioma Cases As Two Groups According to Their Size.

Authors:  Hasan Burak Gündüz; Ayşegül Esen Aydın; Seda Yağmur Karataş Okumuş; Orhun Mete Çevik; Özden Erhan Sofuoğlu; Mustafa Levent Uysal; Murad Asiltürk; Müslüm Güneş; Talat Cem Ovalıoğlu; Erhan Emel
Journal:  Cureus       Date:  2021-11-18

8.  Atypical Histological Features as Risk Factors for Recurrence in Newly Diagnosed WHO Grade I Meningioma.

Authors:  Keitaro Chiba; Takashi Sugawara; Daisuke Kobayashi; Akihito Sato; Yasuhiro Murota; Taketoshi Maehara
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-09-01       Impact factor: 1.742

9.  Preoperative risk factors associated with new focal neurological deficit and other major adverse events in first-time intracranial meningioma neurosurgery.

Authors:  Freya Sophie Jenkins; Flavio Vasella; Luis Padevit; Valentino Mutschler; Kevin Akeret; Julia Velz; Luca Regli; Johannes Sarnthein; Marian Christoph Neidert
Journal:  Acta Neurochir (Wien)       Date:  2021-07-14       Impact factor: 2.216

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.